Table 1.
Specified baseline disease characteristics within selected trials
MDS disease status
.
No. of trials
.
Lower risk only
38
Higher risk only
110
Lower and higher risk
14
Treatment naïve
12
Relapsed/refractory
86
Treatment naïve and relapsed/refractory
27
MDS disease status
.
No. of trials
.
Lower risk only
38
Higher risk only
110
Lower and higher risk
14
Treatment naïve
12
Relapsed/refractory
86
Treatment naïve and relapsed/refractory
27
View Large
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal